Ciprofloxacin
Recommended · restricted Infectious diseaseAuthority Required
Treatment of chronic suppurative otitis media (CSOM) caused by organisms susceptible to ciprofloxacin in adults and children 1 month and older.
1
Submissions
2006–06
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Jul 2006Recommended · restricted
vs Sofradex (dexamethasone with framycetin sulfate and…
- PBS listing · Authority Required
RecommendedDeferredNot recommended
Cost-effectiveness
No numeric ICER range stated. Economic model presented cost-savings per week of earlier resolution: $10.30 saved per week (rural) and $23.40 saved per week (urban).
The Committee considered that economic analysis provided in the submission is adequate to provide confidence that the product would be of acceptable cost effectiveness. PBAC · 2006
Decision context
PopulationAboriginal and Torres Strait Islander (ATSI) persons aged one year and older with chronic suppurative otitis media.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2006 | Recommended · restricted | Sofradex (dexamethasone with framycetin sulfate and gramicidin) | — | RCT · clinical cure |